Wenbo Shao

机构：Shandong Tumor Hospital, First Affiliated Hospital of Henan University, Shandong First Medical University

发表论文 21 篇 · 总被引 183 次 · h-index 9

代表论文

• Significant efficacy and well safety of apatinib in an advanced liver cancer patient: a case report and literature review (2017 · Oncotarget · 被引 39)
• Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study (2023 · Journal of Hepatocellular Carcinoma · 被引 23)
• Activation of ETA Receptor by Endothelin-1 Induces Hepatocellular Carcinoma Cell Migration and Invasion via ERK1/2 and AKT Signaling Pathways (2015 · The Journal of Membrane Biology · 被引 23)
• Association between Glutathione S-Transferase T1, M1, and P1 Genotypes and the Risk of Colorectal Cancer (2014 · Journal of Korean Medical Science · 被引 14)
• Lenvatinib targets STAT-1 to enhance the M1 polarization of TAMs during hepatocellular carcinoma progression (2024 · BMC Cancer · 被引 13)
• Nobiletin alleviates macrophage M2 polarization by activating AMPK-mTOR-mediated autophagy in pulmonary fibrosis mice (2024 · International Immunopharmacology · 被引 13)